Chronic exposure to ultraviolet radiation suppresses T cell-mediated immune responses and induces the formation of suppressor T lymphocytes that prevent the rejection of highly antigenic ultraviolet-induced skin cancers in mice. Tamarind seed xyloglucans and pectinic oligogalacturonides prevent suppression of delayed-type hypersensitivity immune responses in mice to Candida albicans and alloantigen caused by a single exposure of ultraviolet radiation. We therefore investigated the ability of these poly/oligosaccharides to prevent suppression of T cell-mediated immune responses and suppressor cell induction during chronic ultraviolet irradiation and to preserve the capacity of ultraviolet-irradiated mice to reject a transplanted, highly antigenic, ultraviolet-induced tumor. C3H/HeN mice were treated 3Q per week for 12 wk with 15 kJ per m 2 ultraviolet B radiation followed by application of the polysaccharides/ oligosaccharides. The delayed-type hypersensitivity responses to C. albicans and alloantigen were measured after 1, 6, and 12 wk of treatment. Following the 12th wk of treatment the remaining mice were injected with the highly antigenic ultraviolet-induced, syngeneic tumor cell line UV5497-5. The polysaccharides/oligosaccharides protected delayed-type hypersensitivity responses to C. albicans but not contact hypersensitivity responses to dinitro¯uorobenzene for up to 6 wk of ultraviolet radiation after which protection declined and suppressor cells were observed. In contrast, the delayedtype hypersensitivity response to alloantigen was preserved for the entire 12 wk of ultraviolet irradiation. Despite protection of immunity to alloantigen, the transplanted tumor cells grew equally well in all ultraviolet-irradiated animals. These results indicate that delayed-type hypersensitivity responses are heterogeneous and that delayed-type hypersensitivity to alloantigen is not a surrogate marker for rejection of ultraviolet-induced skin tumors. Key words: alloantigen/Candida albicans/chronic ultraviolet B/contact hypersensitivity/delayed-type hypersensitivity/oligosaccharides/polysaccharides/suppression/tolerance. J Invest Dermatol 116: 62±68, 2001 
Chronic exposure to ultraviolet radiation suppresses T cell-mediated immune responses and induces the formation of suppressor T lymphocytes that prevent the rejection of highly antigenic ultraviolet-induced skin cancers in mice. Tamarind seed xyloglucans and pectinic oligogalacturonides prevent suppression of delayed-type hypersensitivity immune responses in mice to Candida albicans and alloantigen caused by a single exposure of ultraviolet radiation. We therefore investigated the ability of these poly/oligosaccharides to prevent suppression of T cell-mediated immune responses and suppressor cell induction during chronic ultraviolet irradiation and to preserve the capacity of ultraviolet-irradiated mice to reject a transplanted, highly antigenic, ultraviolet-induced tumor. C3H/HeN mice were treated 3Q per week for 12 wk with 15 kJ per m 2 ultraviolet B radiation followed by application of the polysaccharides/ oligosaccharides. The delayed-type hypersensitivity responses to C. albicans and alloantigen were measured after 1, 6, and 12 wk of treatment. Following the 12th wk of treatment the remaining mice were injected with the highly antigenic ultraviolet-induced, syngeneic tumor cell line UV5497-5. The polysaccharides/oligosaccharides protected delayed-type hypersensitivity responses to C. albicans but not contact hypersensitivity responses to dinitro¯uorobenzene for up to 6 wk of ultraviolet radiation after which protection declined and suppressor cells were observed. In contrast, the delayedtype hypersensitivity response to alloantigen was preserved for the entire 12 wk of ultraviolet irradiation. Despite protection of immunity to alloantigen, the transplanted tumor cells grew equally well in all ultraviolet-irradiated animals. These results indicate that delayed-type hypersensitivity responses are heterogeneous and that delayed-type hypersensitivity to alloantigen is not a surrogate marker for rejection of ultraviolet-induced skin tumors. Key words: alloantigen/Candida albicans/chronic ultraviolet B/contact hypersensitivity/delayed-type hypersensitivity/oligosaccharides/polysaccharides/suppression/tolerance. J Invest Dermatol 116: 62±68, 2001 E xcessive exposure to ultraviolet (UV) radiation is harmful, causing sunburn, premature aging of the skin, and mutations leading to skin cancer (Urbach, 1989; Ullrich, 1995) . Studies in laboratory animals have shown that UV radiation in the``B'' range (280± 320 nm) of the electromagnetic spectrum also contributes to the growth of highly antigenic skin cancers by suppressing T cellmediated immune responses and inducing the formation of tumor-speci®c suppressor T cells (Kripke, 1974; Fisher and Kripke, 1977) .
Suppression of immune responses to skin tumors occurs at lower doses of UV radiation than are required to cause malignant transformation (Kripke, 1974; De Fabo and Kripke, 1979; Sontag et al, 1997) . Complete suppression of tumor immunity requires the repeated delivery of a subcarcinogenic dose of UV radiation over a period of several weeks.
Model systems designed to clarify the role of the immune response in tumor rejection show that UV radiation suppresses a variety of T cell-mediated immune responses to haptens and protein antigens. Cutaneous exposure of mice to low (suberythemal) doses of UV radiation locally inhibits the induction of contact hypersensitivity (CHS) response to hapten applied through the irradiated skin but not to antigen applied at a distant unirradiated site (Toews et al, 1980) . A single exposure to higher doses of UVB radiation induces systemic suppression of CHS responses to hapten applied to unirradiated sites and of delayed-type hypersensitivity (DTH) responses to both alloantigen and infectious agents, including herpes simplex virus, leishmania, Candida albicans, and mycobacteria (Giannini, 1986; Otani and Mori, 1987; Denkins et al, 1989; Jeevan and Kripke, 1989) . Yoshikawa et al (1990) this suppression is relevant to humans as susceptibility to UVinduced immune suppression of CHS responses is a risk factor for the development of human skin cancer. Results obtained using model antigens and a single exposure to much lower amounts of UV radiation than are required to induce tumors or suppress tumor immunity are frequently equated to mechanisms involved in tumor rejection with little evidence of their parity. There are several reasons why it is important to con®rm these results using chronic UV irradiation. First, the amounts of UV radiation required to cause malignant transformation and to suppress tumor-speci®c immune responses are different. UV carcinogenesis requires high doses of UV radiation given over a long period of time and re¯ects both the accumulation of genetic mutations and factors, such as immune suppression that contribute to progression of the neotransformed cells Sontag et al, 1997) . Second, although partial suppression of T cellmediated responses to UV-induced tumors can be accomplished by a single, very high dose of UVB radiation, complete, long-lived suppression of tumor immunity requires at least 5 wk of UV exposure at a cumulative dose of 150 kJ per m 2 UVB radiation (Kripke, 1974) . Third, a single exposure to UV radiation is less effective at suppressing tumor rejection responses than the same amount of radiation is fractionated and given as multiple smaller doses, suggesting that the biologic responses to these two treatment regimens differ (De Fabo and Kripke, 1979) . Finally, Steerenberg et al (1998) failed to ®nd a correlation between CHS responses to hapten and UV carcinogenesis in SKH-1 mice. Their results showed that the plant¯avonoid quercetin, completely protected CHS responses to picryl chloride from suppression by chronic exposure to UV radiation but did not affect the onset or growth of UVB-induced nonmelanoma skin tumors. Thus, data obtained using model antigens or a single exposure to much lower amounts of UV radiation than are required to induce tumors or suppress tumor immunity may not re¯ect mechanisms involved in tumor rejection.
Currently, the role of DTH responses in the rejection of nonmelanoma tumors induced by chronic UV irradiation is unclear both in humans and laboratory animals. We have used biologically active plant polysaccharides and oligosaccharides as pharmacologic probes of mechanisms of immune suppression by UV radiation (Byeon et al, 1998; Strickland et al, 1999) . The results of those studies showed that both tamarind seed xyloglucan (XG) polysaccharides and pectinic oligalacturonide (OGA) oligosaccharides were effective at preventing suppression of DTH immune responses from a single exposure with up to 30 kJ per m 2 UVB radiation (Strickland et al, 1999) . Our study assesses protection of CHS to dinitro¯uorobenzene (DNFB) and DTH responses in C3H mice to C. albicans and alloantigen afforded by the polysaccharides/ oligosaccharides to chronic exposure to UV radiation. We further investigate the relationship between immune responses to these model antigens and the ability of the mice to reject a UV-induced, syngeneic ®brosarcoma.
MATERIALS AND METHODS
Mice Speci®c-pathogen-free (murine tumor virus-negative, MTV ± ) female C3H/HeN mice were purchased from the Animal Production Area of the Frederick Cancer Research Facility (Frederick, MD). Female BALB/C mice were purchased from Harlan Sprague Dawley (Houston, TX). All animals were maintained in a pathogen-free barrier facility in accordance with National Institutes of Health and American Association for Assessment and Accreditation of Laboratory Animal Care International guidelines. The mice were housed in ®lter-protected cages and provided with National Institutes of Health open formula mouse chow and sterile water ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee. Each experiment was performed with agematched mice 10±12 wk old.
Tumor cell line The UV5497-5 cell line was recently derived from a UV-induced ®brosarcoma from a C3H/HeN mouse and was a kind gift from Dr. Margaret Kripke, Department of Immunology, MD Anderson Cancer Center. The cells were grown in antibiotic-free minimal essential medium supplemented with 10% fetal bovine serum, 200 mM L-glutamine, vitamins, and nonessential amino acids (Gibco, Grand Island, NY), and maintained in our laboratory.
UV radiation UV radiation was administered in vivo using a bank of six un®ltered FS40 sunlamps (National Biological, Twinsburg, OH) . Approximately 65% of the energy emitted from these lamps is within the UVB range (280±320 nm) and the peak emission is at 313 nm. The average irradiance of the source was approximately 7.1 W per m 2 at 20 cm distance, as measured by an IL1700 radiometer with an SEE280 ®lter and a Watt quartz diffuser (International Light, Newburyport, MA).
Preparation of polysaccharides/oligosaccharides Ten grams of tamarind seed powder (C.E. Roeper GmbH, Hamburg, Germany) was suspended in 2 liters of water, stirred overnight at 4°C and centrifuged for 30 min at 10,000 rpm using a JA-10 rotor and Beckman J2-HS centrifuge (Beckman Instruments, Palo Alto, CA). The supernatant was collected and adjusted with 100% ethanol to a ®nal concentration of 70% and chilled overnight at 4°C. The precipitate containing the XG was collected by centrifugation for 30 min at 10,000 rpm. The pellet was dissolved in water and lyophilized.
Polygalacturonic acid (Sigma, St Louis, MO) was dissolved in 20 mM sodium acetate pH 5.0 to make a 2% solution and 5 ppm bovine serum albumin was added. The solution was treated for 8 h at ambient temperature with a-(1-4)-endopolygalacturonase puri®ed from Fusarium moniliforme. The enzymatic reaction was stopped by autoclaving the solution for 15 min. To precipitate the OGA, the solution was adjusted to 50 mM sodium acetate by addition of sodium acetate crystals and with 100% ethanol to a ®nal concentration of 11%. The mixture was kept at 4°C overnight. The precipitate was collected by centrifugation for 30 min at 12,500 rpm at 4°C, redissolved in water, dialyzed (2000 mW cutoff SpectraPor7 tubing, Spectrum Medical Industries, Los Angeles, CA), and lyophilized. These polysaccharides/oligosaccharides do not absorb UV light at wavelengths above 220 nm.
Treatment of mice Tamarind and OGA polysaccharides/ oligosaccharides were dissolved in phosphate-buffered saline (PBS) in 1 mg per ml and 100 mg per ml concentrated stock solutions and stored at ±20°C. Each week a fresh working stock solution was prepared and stored at 4°C. The dorsal fur of mice was shaved with electric clippers at least once weekly. The animals were put into cages covered with a wire lid. The incident light received by the animals under these conditions was reduced to 2.6 W per m 2 , by shielding from the wire cage top. The animals were exposed to 15 kJ per m 2 UVB radiation 3Q per wk for 12 wk. Within 1 h after each UV irradiation, the UV-exposed skin was treated with 1 mg each of tamarind XG polysaccharide or OGA in PBS. As some polysaccharides/ oligosaccharides adhere tightly to cellulose, the materials were manually applied using latex gloves. Control animals were treated in an identical manner but were not exposed to UV radiation. At 1 wk, 6 wk, and 12 wk after the start of the experiment and 2 h after the last treatment, groups of ®ve mice were injected subcutaneously in each¯ank with 1Q10 7 formalin-®xed C. albicans cells. Other mice were injected with 5Q10 7 each BALB/C spleen cells. Ten days after sensitization, the mice were challenged with 50 ml of commercially prepared soluble Candida antigen, supplied as a 1 : 100 dilution (Allercheck Laboratories, Portland, ME) in each hind footpad. Animals sensitized with alloantigen were challenged in each hind footpad with 50 ml containing 1Q10 7 BALB/C spleen cells in serum-free RPMI medium. Footpad thickness (dorsal to plantar aspect) was measured immediately before challenge and 24 h later using an engineer's micrometer (Production Tools, Houston, TX). Control mice were not sensitized but were challenged in both hind footpads with soluble Candida antigen or alloantigen. Speci®c footpad swelling was determined by subtracting the average values obtained from mice challenged but not sensitized. After 12 wk, the remaining mice were injected with a single cell suspension of 5Q10 5 syngeneic UV5497-5 tumor cells subcutaneously in the right¯ank of each mouse. A group of 10 untreated C3H/HeN mice were exposed to 450 R X-irradiation 24 h before receiving tumor cells. All mice were inspected weekly for tumor growth.
Suppressor cell assay To determine whether UV radiation-induced suppressor cell formation, the UV-irradiated mice were killed immediately after measurement of their DTH response and their spleens were removed. A single-cell suspension was made, and their splenocytes were washed twice in serum-free RPMI 1640 Medium (Gibco, Grand island, NY). The splenocytes were injected intravenously into naõ Ève C3H mice, 1Q10 8 nucleated cells per animal. A control group received spleen cells from untreated syngeneic animals. The spleen cell recipients were then sensitized with C. albicans or 5Q10 7 BALB/C spleen cells (alloantigen) and challenged 10 d later as described above.
Contact sensitization Groups of ®ve C3H/HeN mice were anesthetized with Nembutal (sodium pentobarbital, 0.01 ml per g body weight; MD Anderson Pharmacy, manufactured by Abbott Laboratories, Northbrook, IL) intraperitoneally and their shaved ventral skin was exposed to a single dose of 2 kJ per m 2 UVB radiation. Control mice were treated in an identical manner but were not exposed to UV radiation. UVirradiated and control mice were sensitized on their shaved abdominal skin by applying 50 ml of 0.3% DNFB in acetone solution 3 d after UV irradiation. Six days after sensitization, the mice were challenged by painting 5 ml of 0.2% DNFB in acetone on the ventral and dorsal surfaces of each ear. Ear thickness was measured using an engineer's micrometer immediately before challenge and 24 h later. Speci®c ear swelling was determined by subtracting the values obtained from the mice that were challenged but not sensitized.
Statistics Statistical analyses were performed using ANOVA or two-tailed Student's t test. P < 0.05 was considered signi®cant. Analyses were performed using Statview 4.5 software (Abacus Concepts, Berkeley, CA) on a Power Macintosh 8600 microcomputer.
RESULTS
Protection of DTH immunity from suppression by acute, repeated exposure to UV radiation We have previously demonstrated that tamarind XG and OGA prevent suppression of DTH immunity to C. albicans and alloantigen by a single exposure to UV radiation (Strickland et al, 1999) . Therefore, we investigated the ability of the therapeutic saccharides to protect DTH immune responses from repeated exposure to UV radiation. The shaved dorsal skin of C3H/HeN mice was treated with 15 kJ per m 2 of UVB three times for 1 wk. A solution of tamarind XG polysaccharides or OGA oligosaccharides in PBS was applied to the irradiated skin of the animals within 1 h after each exposure to UV radiation. Control groups were treated identically but were not UV irradiated. The data from two separate experiments were combined and are presented in Table I . Tamarind XG and OGA appeared to reduce slightly the response to C. albicans in non-UVirradiated mice; however, this effect was not consistent between experiments. In the absence of the polysaccharide/oligosaccharide treatment, UV irradiation severely reduced the DTH responses of the animals to both C. albicans and alloantigen compared with their matched, unirradiated controls. Polysaccharide/oligosaccharide treatment provided partial to complete protection of DTH immunity. Thus, the polysaccharides/oligosaccharides protect systemic DTH immune responses from the suppressive effects of UV radiation administered as either a single exposure to a high dose (30 kJ per m 2 ) or as multiple smaller doses (Strickland et al, 1999) .
Protection of CHS responses
We investigated the speci®city of immune protection by the polysaccharides/oligosaccharides by testing the effectiveness of the compounds in protecting local and systemic CHS responses to hapten. For suppression of local immunity, the shaved ventral skin of C3H/HeN mice was exposed to 2 kJ per m 2 UVB radiation and treated with tamarind XG/PBS, OGA/PBS, or PBS alone. The UV-irradiated and unirradiated controls were sensitized with the hapten, DNFB 3 d later. Exposure to UV radiation reduced the response of mice to DNFB by greater than 50% compared with their nonirradiated, matching controls (Table II) . Neither tamarind XG nor OGA restored immunity to the hapten even though the dose of UV radiation used in these experiments was far less than those used to suppress DTH immunity, as shown in Table I . Tamarind and OGA polysaccharides/oligosaccharides also failed to prevent systemic suppression of CHS responses to DNFB when the mice were given a higher (15 kJ per m 2 ) UV radiation and sensitized through unirradiated skin (not shown). Taken together, the results show that tamarind XG and OGA polysaccharides/oligosaccharides activity is speci®c for the pathways involved in the UV-induced suppression of systemic DTH immune responses but does not protect CHS immunity to hapten.
Effect of polysaccharides/oligosaccharides on DTH immunity and suppressor T cells induction during chronic UV irradiation As amounts of UV radiation necessary to suppress tumor immunity are greater than those required to suppress T cell responses to model antigens, we determined the ability of the polysaccharides/oligosaccharides to protect DTH responses from the effects of a subcarcinogenic treatment with UV radiation (Kripke, 1974; De Fabo and Kripke, 1979 ; Sontag et al, f Mice were exposed on their shaved dorsal skin to 15 kJ per m 2 UVB from FS40 sunlamps three times per week and sensitized 2 h after the last treatment. g Determined by ANOVA. NS, p > 0.05. h UV-irradiated skin was treated with tamarind or OGA immediately after each UV exposure. The mice were sensitized 2 h after the last treatment. i Mice were challenged in each hind footpad with 1 Q 10 7 BALB/C spleen cells. j Each mouse was sensitized subcutaneously with 5 Q 10 7 BALB/C spleen cells. 1997). Using the chronic UV irradiation model described by De Fabo and Kripke (1979) , the mice were UV irradiated 3Q per week for 12 wk. After each UV exposure, the animals and their unirradiated control groups were treated with tamarind XG or OGA. Groups of UV-irradiated and nonirradiated control animals were removed from the experiment after 6 and 12 wk of treatment (cumulative dose of UVB: 270 kJ per m 2 and 540 kJ per m 2 , respectively) to assess their DTH response to C. albicans and alloantigen. Chronic UV irradiation reduced the DTH responses of the animals to C. albicans (Table III) and alloantigen (Table IV) to near background levels compared with unirradiated matching control groups. Tamarind XG and OGA treatment provided partial protection of DTH immunity to C. albicans from 6 wk of chronic UV irradiation but protection was lost by 12 wk of treatment (left half of Table III) . Unlike the DTH response to C. albicans, however, both tamarind XG and OGA were highly effective at preventing suppression of DTH responses to alloantigen even after 12 wk of UV irradiation (left half of Table IV) . Suppressor T lymphocytes found in the spleen of chronically UV-irradiated mice, contribute to the growth of highly antigenic skin tumors by preventing their antigen-speci®c immune rejection (Fisher and Kripke, 1974) . We therefore assessed the presence of suppressor cells in the UV-irradiated animals after 6 and 12 wk of treatment by transferring the spleen cells from the UV-irradiated, untreated or polysaccharide-treated animals to syngenic, unimmunized recipients. Spleen cells from untreated donor mice given 6 and 12 wk of UV radiation inhibited the induction of DTH response to C. albicans (right half Table III ) and alloantigen (right half Table IV) in the syngeneic recipient animals. OGA blocked suppressor cell formation to Candida antigen in mice treated for up to 6 wk with UV radiation; however, by 12 wk of UV treatment the immunoprotective activity of the OGA was overcome (Table III) . Tamarind XG was less effective than OGA at preventing the generation of suppressor cells and its protective activity was overcome by 6 wk of UV treatment (cumulative dose 270 kJ per m 2 ). Unlike immune responses to C. albicans, both tamarind XG and OGA were equally effective in preventing the formation of splenic suppressor cells to alloantigen even in animals f Each mouse was treated with 1 ml of a solution of 1 mg per ml tamarind XG or OGA in PBS. The mice were sensitized with 0.3% DNFB in acetone 3 d later and challenged 6 d after sensitization.
g Mice were exposed to 2 kJ per m 2 UVB from FS40 sunlamps on their shaved abdominal skin. The mice were sensitized with 0.3% DNFB in acetone 3 d later and challenged 6 d after sensitization.
h UV-irradiated skin was treated with tamarind XG or OGA immediately after exposure. The mice were sensitized with 0.3% DNFB 3 d later and challenged 6 d after sensitization. treated with UV radiation for 12 wk (right half Table IV) . Taken together, these results show that DTH responses are complex and that conditions that favor the generation of suppressor cells speci®c for one antigen may not result in the generation of suppressor cells to a different antigen. They further suggest that all surrogate markers for tumor immunity are not alike. Therefore, we directly examined the relationship between DTH responses to the model antigens and tumor immunity.
Effect of tamarind XG and OGA on tumor immunity Mice remaining in the experiments after the 12 wk of treatment described above but that were not immunized, were injected subcutaneously with cells from a highly antigenic, syngenic regressor tumor. This cell line, UV5497-5, was recently derived from a ®brosarcoma arising in the skin of a C3H/HeN mouse during chronic treatment with UV radiation. A normal (untreated) age-matched group of mice was exposed to a sublethal dose of Xirradiation and injected with the tumor cells as a positive control for tumor growth. The data presented in Fig 1 are from one of two experiments and show that the tumor cells grew rapidly in all the mice whose immune system was suppressed by the X-irradiation. Only 10±20% of unirradiated, non-UV-exposed mice developed tumors. The tumor cells injected into these mice produced palpable tumors that were too small to measure accurately and were completely rejected 4 wk after transplantation. Neither tamarind XG nor OGA affected tumor incidence or growth in non-UVirradiated mice. In contrast, tumors progressively developed in all UV-irradiated, untreated or polysaccharide/oligosaccharide-treated mice. Once these tumors appeared, they progressively grew in size until the animals were moribund and had to be killed (not shown). Neither the tamarind XG or OGA polysaccharides/oligosaccharides signi®cantly affected the appearance of tumors or their rate of growth compared with the untreated, UV-irradiated group (not shown). Thus, protection of immune responses to alloantigen from suppression by chronic UV irradiation was unrelated to the ability of the animal to reject a transplanted, highly immunogenic, UV-induced skin tumor. Challenged in the hind footpads with 1 Q 10 7 BALB/C spleen cells per mouse but not sensitized. e Sensitized subcutaneously with 5 Q 10 7 BALB/C spleen cells (alloantigen) per mouse. f Each mouse was treated 3Q per week with 1 ml of a solution of 1 mg per ml tamarind XG or OGA in PBS. The mice were sensitized with antigen after the last treatment.
g NR, spleen cells from unimmunized, syngeneic animals. h Mice were exposed to 15 kJ per m 2 UVB 3Q per week and sensitized with BALB/C spleen cells 2 h after the last treatment. i Determined by ANOVA. p > 0.05 = NS (not signi®cant). j 1 Q 10 8 nucleated spleen cells per mouse from donors in the left half of the table were transferred intravenously to unimmunized, syngeneic recipients. The spleen cell recipients were then sensitized with alloantigen. k UV-irradiated skin was treated with 1 mg per ml tamarind XG or OGA in PBS immediately after each UV exposure. The mice were sensitized with alloantigen 2 h after the last treatment. Figure 1 . Effect of tamarind XG polysaccharide and OGA oligosaccharide on the growth of a transplanted UV-induced tumor. Groups of 10 C3H/HeN mice were exposed to 15 kJ per m 2 UVB radiation followed by treatment of the irradiated skin with 1 mg tamarind XG/PBS, OGA/PBS, or PBS alone. The UV-irradiated and nonirradiated control groups were treated 3Q per week for 12 wk followed by transplantation subcutaneously of 5 Q 10 5 UV5497-5 tumor cells. One group of untreated, normal C3H mice was X-irradiated (450 R) 24 h before receiving the tumor cells. The results shown are from one of two separate experiments.
DISCUSSION
Application of tamarind XG and OGA polysaccharides/oligosaccharides to the UV-irradiated skin of mice protects DTH responses to both C. albicans and alloantigen from suppression by a single exposure of UVB radiation (Strickland et al, 1999) . Our study extends those investigations to assess the ability of the compounds to prevent suppression from repeated acute UV exposure over a short period and from chronic UV exposure at levels suf®cient to suppress tumor immunity. The results show that the therapeutic saccharides progressively lose their ability to protect DTH immune responses to C. albicans, but not alloantigen during the course of chronic UV irradiation. Thus, there are signi®cant differences in the regulation of DTH immune responses to the two antigens during chronic UV treatment that are not re¯ected in acute models of UV-induced immune suppression.
One explanation for these differences may be that the relationship between the tissue damage caused by UV radiation and the host response to the injury is dynamic and changes with time. In our study, this interaction could account for the progressive loss of protection of DTH responses to C. albicans and the appearance of suppressor cells in the spleens of the UV-irradiated, polysaccharide/ oligosaccharide-treated animals over time. Biologic adaptation has been shown to occur during chronic exposure to UV radiation and may in¯uence the ®nal outcome of treatment. During early phases of chronic UV irradiation, Ia + and DETC cells are depleted from the epidermis followed by an increase in Ia + but not DETC cells (Alcalay et al, 1989) . Antigen-presenting cell functions are also impaired during chronic UV irradiation, but recover when tumor development occurs (Alcalay and Kripke, 1991) . Biologic adaptation to chronic UV irradiation also occurs in the effector phase of the immune response. For example, recall responses in humans to puri®ed protein derived antigens measured by the Mantoux skin test, were signi®cantly more suppressed by acute UV irradiation than by prolonged UV exposure, indicating that adaptive mechanisms may have counteracted some of the immunosuppressive effects of UV radiation (Damian et al, 1998) . Changes in regulation of immune responses over time are not restricted to the biologic consequences of exposure to UV radiation. Repeated administration of antigen or the chemical properties of an antigen both in¯uence T cell and B cell responses, resulting in changing immunoglobulin gene rearrangements and expression of B cell subpopulations over time (Strickland et al, 1989) . Thus, regulation of immune responses is complex, changes with time, and is antigen dependent.
The mechanism of regulation of immune responses to different antigens by acute or chronic UV irradiation are poorly understood. Work from several laboratories demonstrate that acute exposure to UV radiation suppresses CHS and DTH responses by different mechanisms (Kripke and Morison, 1986; Daynes et al, 1986; Beissert and Granstein, 1995; Moodycliff et al, 1996; Kim et al, 1998) . Suppression of CHS responses by UV radiation is triggered by DNA damage-mediated pathways and involves alterations in Langerhans cell functions, the release of tumor necrosis factor-a, interleukin (IL)-1 cytokines, and prostaglandin E 2 (Chung et al, 1986; Robertson et al, 1987; Harriott-Smith and Haliday, 1988; Vermeer and Streilein, 1990; Simon et al, 1991) . Enzymatic repair of UV-induced cyclopyrimidine dimers restores the immune response to haptens and the DTH response to C. albicans Vink et al, 1996) . In contrast, antibodies speci®c for cisurocanic acid (cis-UCA) and IL-10 block UV-induced systemic suppression of DTH responses to alloantigen and herpes simplex virus but not local CHS responses to haptens (Noonan and De Fabo, 1992; Ullrich, 1994; Moodycliff et al, 1996) . Cis-UCA has been found systemically to suppress CHS responses to haptens through its action on mast cells (Hart et al, 1999) . The roles of regulatory pathways triggered by DNA damage or cis-UCA in the suppression of immunity by chronic UV irradiation are currently unknown.
Tamarind XG and OGA are probably not exerting their protective effects directly by stimulating the repair of UV-induced DNA damage as the immune-protective polysaccharides/oligosaccharides from aloe do not stimulate repair of cybutylpyrimidine dimers in UV-irradiated murine skin (Strickland et al, 1994) . Polysaccharides/oligosaccharides from tamarind XG, OGA, and aloe, however, can preserve DTH immunity by preventing the production of immunosuppressive cytokines such as IL-10 by UVirradiated keratinocytes in vivo and in vitro (Strickland et al, 1999) . Although in our model the polysaccharides/oligosaccharides do not block the isomerization of trans-to cis-UCA because they were applied to the skin after UV irradiation, they may in¯uence the regulation of pathways triggered by cis-UCA. Further studies are needed to determine the action of the polysaccharides/oligosaccharides on these pathways during chronic UV irradiation.
This study was undertaken in part to clarify the role of DTH to contact allergens (CHS) and DTH immune responses to proteins in rejection of UV-induced nonmelanoma skin cancer. Both CHS and DTH responses are delayed-in-time and are T cell-mediated, although CHS immune responses are generally thought to be a subset of DTH immunity. Donawho et al (1992) showed that suppression of DTH responses to protein antigens but not CHS to hapten was important in UV enhanced outgrowth of melanoma. Similarly, Steerenberg et al (1997) were unable to correlate protection of CHS immune responses to picryl chloride and UV carcinogenesis, suggesting a dissociation between CHS and tumor immunity; however, the conditions used by these authors would also suppress DTH immunity to protein antigens. The ability of quercetin to protect DTH responses from suppression by UV radiation has not, to our knowledge, been reported. The selective protection of DTH immunity in the absence of protection of CHS responses in our model provides the unique opportunity for elucidating the role of DTH in the rejection of nonmelanoma skin cancer. Our ®ndings that DTH immunity to alloantigen did not correlate with tumor rejection have several interpretations. First, T cell-mediated immune responses are complex and antigen dependent. The correlation between the loss of DTH to C. albicans and failure to reject a highly antigenic tumor may re¯ect the nature of the antigens, their processing, the subpopulations of antigen-presenting cells, and suppressor T cells involved. Quercetin preserves the function of Langerhans cells in the skin but may not affect antigen-presenting cells in the spleen (Steerenberg et al, 1997) . DTH immunity to alloantigen and C. albicans involves differences in both antigen processing and presentation. Second, CHS responses to DNFB and DTH to C. albicans are mechanisms required for tumor rejection. This interpretation agrees with the ®ndings of Yoshikawa et al (1990) , who correlated tumor susceptibility in humans with sensitivity to the suppressive effects of UV radiation on CHS responses. A negative association (lack of responsiveness to the model antigen and failure to reject a transplanted tumor), however, does not conclusively demonstrate a causal relationship between these immune pathways and a mechanism for tumor rejection. Finally, the recognition and rejection of nonmelanoma skin tumors may require both CHS and DTH immune pathways to be intact. This hypothesis can be tested using a combination of agents that selectively protect CHS and DTH immune responses.
The relationship between suppressor cells speci®c for the model antigens or for tumor is at present unknown. Also unknown is the nature of the antigen shared by UV-induced tumors and recognized by effector and suppressor T cells. In this study, suppressor cells speci®c for C. albicans antigen appeared in the polysaccharide/ oligosaccharide-treated groups after approximately 6 wk of irradiation and increased by 12 wk of UV irradiation whereas the polysaccharides/oligosaccharides completely blocked the generation of these cells to alloantigen. Despite the absence of suppression of DTH immunity to antigen, the mice were unable to reject a highly antigenic transplanted skin tumor. These results suggest that suppressor cells are heterogeneous and that under the same conditions, they may be present to one antigen and absent for another. Evidence for the heterogeneity of UV-induced suppressor T cell populations was provided by our laboratory (Shreedhar et al, 1998) and by Moodycliffe et al (1999) . The results from those studies showed that cloned, UV-induced, hapten-speci®c suppressor T lymphocytes belonged to the Tr-1 family of regulatory T cells whereas CD4 + NK-1.1 + T cells suppress DTH immune responses to proteins and tumor antigens. The results of the current study indicate that DTH immunity is more complex than was previously thought and the mechanisms of UV-induced suppression to different antigens must be further clari®ed.
In summary, our results demonstrate that there can be signi®cant differences between the effects of acute and chronic UV radiation on immune responses to model antigens. Furthermore, caution must be used when extrapolating the results from surrogate tests for tumor immunity to actual capacity to reject tumors as DTH immune responses are more complex than were previously thought. More work is necessary to clarify mechanisms involved in the suppression of immune responses to model antigens by chronic UV radiation, the mechanisms of antigen-speci®c suppressor cell induction, and their relation to tumor immunity.
